TITLE:
Sustained long-term clinical and radiological response with sunitinib for metastatic renal-cell carcinoma (RCC)
AUTHORS:
K. I. Quintyne, T. Neenan, F. Wallis, R. K. Gupta
KEYWORDS:
Renal Cell Carcinoma; Biological Therapy; Sunitinib; Long Term Use
JOURNAL NAME:
Case Reports in Clinical Medicine,
Vol.2 No.1,
March
22,
2013
ABSTRACT: The authors herein report the case of a 67-year-old woman with
metastatic renal-cell carcinoma (RCC), who has had a sustained clinical and
stable radiological response to long-term therapy with an oral multi-targeted
tyrosine kinase inhibitor (TKI), sunitinib
with minimal lasting toxicity.